London +4420 814 42225
Moscow +7495 543 9194
Kiev +38044 599 2950

Our Clients

Order Informer

Home > News >

COVID-19 - News digest as of 25.02.2021

February 25/2021

1. Siegfried reports higher profits, sales with growth in all businesses

MOSCOW (MRC) -- Siegfried says its core net profit for 2020 increased 10.4%, to 72.2 million Swiss francs (USD79.6 million) on sales up 1.4%, to SFr845.1 million, said Chemweek. Core EBITDA also grew by 6.2%, to SFr149.4 million. The positive performance was driven by growth in the companys two businesses with sales in drug substances going up 1.4%, to SFr647.8 million, and drug products sales increasing 1.2%, to SFr197.2 million. Fourth-quarter figures have not been disclosed. Siegfried expects a significant jump in sales in 2021, to well above SFr1 billion, driven by robust organic growth in all business areas, the contributions of the two former Novartis sites, and the additional business from a cooperation and supply agreement with BioNTech for the Pfizer/BioNTech COVID-19 vaccine.
Author:Anna Larionova
Tags:petroleum products, neftegaz, COVID-19.
Category:General News
| More

Leave a comment

MRC help


 All News   News subscribe